These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Women and ARV-based HIV prevention - challenges and opportunities. Geary CW, Bukusi EA. J Int AIDS Soc; 2014; 17(3 Suppl 2):19356. PubMed ID: 25224621 [Abstract] [Full Text] [Related]
6. Community and research staff collaboration for development of materials to inform microbicide study participants in Africa. Woodsong C, Mutsambi JM, Ntshele S, Modikoe P. J Int AIDS Soc; 2014; 17(3 Suppl 2):19156. PubMed ID: 25224615 [Abstract] [Full Text] [Related]
7. ARV-based HIV prevention for women - where we are in 2014. Mastro TD, Sista N, Abdool-Karim Q. J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614 [Abstract] [Full Text] [Related]
8. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city. Peitzmeier SM, Tomko C, Wingo E, Sawyer A, Sherman SG, Glass N, Beyrer C, Decker MR. AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718 [Abstract] [Full Text] [Related]
10. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa. Miller L, Morar N, Kapiga S, Ramjee G, Hayes R. J Acquir Immune Defic Syndr; 2020 Dec 01; 85(4):458-465. PubMed ID: 33136745 [Abstract] [Full Text] [Related]
11. A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand. Newman PA, Roungprakhon S, Tepjan S. J Int AIDS Soc; 2013 Aug 01; 16(1):18476. PubMed ID: 23911116 [Abstract] [Full Text] [Related]
12. Male engagement in women's microbicide use in Kenya: Navigating gender norms. Schuler SR, Bukusi E. Health Care Women Int; 2017 May 01; 38(5):507-519. PubMed ID: 28273003 [Abstract] [Full Text] [Related]
13. WHO guidance grounded in a comprehensive approach to sexual and reproductive health and human rights: topical pre-exposure prophylaxis. Lusti-Narasimhan M, Khosla R, Baggaley R, Temmerman M, McGrory E, Farley T. J Int AIDS Soc; 2014 May 01; 17(3 Suppl 2):19279. PubMed ID: 25224620 [Abstract] [Full Text] [Related]
15. Clinical development of microbicides for the prevention of HIV infection. D'Cruz OJ, Uckun FM. Curr Pharm Des; 2004 May 01; 10(3):315-36. PubMed ID: 14754390 [Abstract] [Full Text] [Related]